Mbx Biosciences Inc (Symbol: MBX) is currently trading at $30.76 per share. Investors considering purchasing shares may find selling put options, particularly the January 2028 put at the $20 strike with a bid of $5.00, an attractive alternative. This strategy offers a potential return of 25% against the commitment of $20, translating to an annualized rate of return of 12.1%.
The put seller only acquires shares if the contract is exercised, which requires a 34.8% decline in stock price for an effective cost basis of $15.00 per share, after accounting for the premium received. Mbx Biosciences Inc has a trailing twelve-month volatility of 119%, based on the last 249 trading days, which may help investors assess the risk versus reward of this strategy.
For further details on put options for Mbx Biosciences, interested investors can visit the Stock Options page on StockOptionsChannel.com.
